Top Weight-Loss Drugs to Advertise During Super Bowl

Companies in the weight-loss drug industry are gearing up to make a big splash during the Super Bowl with high-profile ads. Novo Nordisk’s Wegovy pill will feature in a 90-second spot with comedian Kenan Thompson and music producer DJ Khaled. Ro will have tennis star Serena Williams in its ad, while Hims & Hers Health will have rapper Common as the voiceover for their commercial.

The move towards direct-to-consumer marketing is evident with the launch of new pill versions of GLP-1 weight-loss drugs. Novo Nordisk and Eli Lilly are both vying for market share with their respective offerings. Lilly’s Zepbound will be advertised during the pre-game show and on NBC’s Peacock streaming service.

The Super Bowl offers a unique opportunity to connect with millions of viewers, making it an attractive platform for companies in the healthcare sector. The high visibility advertising is expected to continue as more companies adopt a direct-to-consumer sales approach. The new Wegovy pill, priced at $149, has seen strong demand in the US market.

Hims recently faced a setback after threats of legal challenges forced them to change the pricing of their GLP-1 pill. Despite the challenges, the company is determined to reach a wider audience and maintain their presence in the market.

Overall, pharmaceutical advertising spending has been supported by the weight-loss category, with GLP-1 ads playing a significant role. The industry is expected to see continued growth as companies focus on reaching consumers directly and offering more affordable options for weight-loss treatment.